Literature DB >> 23824184

Bile acid signal-induced phosphorylation of small heterodimer partner by protein kinase Cζ is critical for epigenomic regulation of liver metabolic genes.

Sunmi Seok1, Deepthi Kanamaluru, Zhen Xiao, Daniel Ryerson, Sung-E Choi, Kelly Suino-Powell, H Eric Xu, Timothy D Veenstra, Jongsook Kim Kemper.   

Abstract

Bile acids (BAs) are recently recognized key signaling molecules that control integrative metabolism and energy expenditure. BAs activate multiple signaling pathways, including those of nuclear receptors, primarily farnesoid X receptor (FXR), membrane BA receptors, and FXR-induced FGF19 to regulate the fed-state metabolism. Small heterodimer partner (SHP) has been implicated as a key mediator of these BA signaling pathways by recruitment of chromatin modifying proteins, but the key question of how SHP transduces BA signaling into repressive histone modifications at liver metabolic genes remains unknown. Here we show that protein kinase Cζ (PKCζ) is activated by BA or FGF19 and phosphorylates SHP at Thr-55 and that Thr-55 phosphorylation is critical for the epigenomic coordinator functions of SHP. PKCζ is coimmunopreciptitated with SHP and both are recruited to SHP target genes after bile acid or FGF19 treatment. Activated phosphorylated PKCζ and phosphorylated SHP are predominantly located in the nucleus after FGF19 treatment. Phosphorylation at Thr-55 is required for subsequent methylation at Arg-57, a naturally occurring mutation site in metabolic syndrome patients. Thr-55 phosphorylation increases interaction of SHP with chromatin modifiers and their occupancy at selective BA-responsive genes. This molecular cascade leads to repressive modifications of histones at metabolic target genes, and consequently, decreased BA pools and hepatic triglyceride levels. Remarkably, mutation of Thr-55 attenuates these SHP-mediated epigenomic and metabolic effects. This study identifies PKCζ as a novel key upstream regulator of BA-regulated SHP function, revealing the role of Thr-55 phosphorylation in epigenomic regulation of liver metabolism.

Entities:  

Keywords:  Bile Acid; CDCA; Cyp7a1; Epigenomics; FGF19; Fibroblast Growth Factor (FGF); Histone Modification; Liver Metabolism; Post-translational Modification

Mesh:

Substances:

Year:  2013        PMID: 23824184      PMCID: PMC3743497          DOI: 10.1074/jbc.M113.452037

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  39 in total

1.  Dual mechanisms for repression of the monomeric orphan receptor liver receptor homologous protein-1 by the orphan small heterodimer partner.

Authors:  Yoon-Kwang Lee; David D Moore
Journal:  J Biol Chem       Date:  2001-10-19       Impact factor: 5.157

2.  Regulation of hepatic metabolic pathways by the orphan nuclear receptor SHP.

Authors:  Konstantinos Boulias; Nitsa Katrakili; Krister Bamberg; Peter Underhill; Andy Greenfield; Iannis Talianidis
Journal:  EMBO J       Date:  2005-06-23       Impact factor: 11.598

3.  Functional role of G9a-induced histone methylation in small heterodimer partner-mediated transcriptional repression.

Authors:  Konstantinos Boulias; Iannis Talianidis
Journal:  Nucleic Acids Res       Date:  2004-11-18       Impact factor: 16.971

4.  Molecular basis for feedback regulation of bile acid synthesis by nuclear receptors.

Authors:  T T Lu; M Makishima; J J Repa; K Schoonjans; T A Kerr; J Auwerx; D J Mangelsdorf
Journal:  Mol Cell       Date:  2000-09       Impact factor: 17.970

Review 5.  Bile acid regulation of gene expression: roles of nuclear hormone receptors.

Authors:  John Y L Chiang
Journal:  Endocr Rev       Date:  2002-08       Impact factor: 19.871

6.  Delivery of adenoviral DNA to mouse liver.

Authors:  Sheila Connelly; Christine Mech
Journal:  Methods Mol Biol       Date:  2004

7.  Role of an mSin3A-Swi/Snf chromatin remodeling complex in the feedback repression of bile acid biosynthesis by SHP.

Authors:  Jongsook Kim Kemper; Hwajin Kim; Ji Miao; Sonali Bhalla; Yangjin Bae
Journal:  Mol Cell Biol       Date:  2004-09       Impact factor: 4.272

8.  Bile acids lower triglyceride levels via a pathway involving FXR, SHP, and SREBP-1c.

Authors:  Mitsuhiro Watanabe; Sander M Houten; Li Wang; Antonio Moschetta; David J Mangelsdorf; Richard A Heyman; David D Moore; Johan Auwerx
Journal:  J Clin Invest       Date:  2004-05       Impact factor: 14.808

Review 9.  Epigenomic regulation of bile acid metabolism: emerging role of transcriptional cofactors.

Authors:  Zachary Smith; Daniel Ryerson; Jongsook Kim Kemper
Journal:  Mol Cell Endocrinol       Date:  2012-05-09       Impact factor: 4.102

10.  Mutations in the small heterodimer partner gene are associated with mild obesity in Japanese subjects.

Authors:  H Nishigori; H Tomura; N Tonooka; M Kanamori; S Yamada; K Sho; I Inoue; N Kikuchi; K Onigata; I Kojima; T Kohama; K Yamagata; Q Yang; Y Matsuzawa; T Miki; S Seino; M Y Kim; H S Choi; Y K Lee; D D Moore; J Takeda
Journal:  Proc Natl Acad Sci U S A       Date:  2001-01-02       Impact factor: 11.205

View more
  25 in total

Review 1.  The orphan nuclear receptors at their 25-year reunion.

Authors:  Shannon E Mullican; Joanna R Dispirito; Mitchell A Lazar
Journal:  J Mol Endocrinol       Date:  2013-11-26       Impact factor: 5.098

2.  Cytoplasmic tyrosine phosphatase Shp2 coordinates hepatic regulation of bile acid and FGF15/19 signaling to repress bile acid synthesis.

Authors:  Shuangwei Li; Diane D F Hsu; Bing Li; Xiaolin Luo; Nazilla Alderson; Liping Qiao; Lina Ma; Helen H Zhu; Zhao He; Kelly Suino-Powell; Kaihong Ji; Jiefu Li; Jianhua Shao; H Eric Xu; Tiangang Li; Gen-Sheng Feng
Journal:  Cell Metab       Date:  2014-06-26       Impact factor: 27.287

3.  Bile acids as global regulators of hepatic nutrient metabolism.

Authors:  Phillip B Hylemon; Kazuaki Takabe; Mikhail Dozmorov; Masayuki Nagahashi; Huiping Zhou
Journal:  Liver Res       Date:  2017-04-26

4.  Obesity-Linked Phosphorylation of SIRT1 by Casein Kinase 2 Inhibits Its Nuclear Localization and Promotes Fatty Liver.

Authors:  Sung E Choi; Sanghoon Kwon; Sunmi Seok; Zhen Xiao; Kwan-Woo Lee; Yup Kang; Xiaoling Li; Kosaku Shinoda; Shingo Kajimura; Byron Kemper; Jongsook Kim Kemper
Journal:  Mol Cell Biol       Date:  2017-07-14       Impact factor: 4.272

5.  Bile acid signaling in lipid metabolism: metabolomic and lipidomic analysis of lipid and bile acid markers linked to anti-obesity and anti-diabetes in mice.

Authors:  Yunpeng Qi; Changtao Jiang; Jie Cheng; Kristopher W Krausz; Tiangang Li; Jessica M Ferrell; Frank J Gonzalez; John Y L Chiang
Journal:  Biochim Biophys Acta       Date:  2014-05-04

6.  Hepatocyte nuclear receptor SHP suppresses inflammation and fibrosis in a mouse model of nonalcoholic steatohepatitis.

Authors:  An Zou; Nancy Magee; Fengyan Deng; Sarah Lehn; Cuncong Zhong; Yuxia Zhang
Journal:  J Biol Chem       Date:  2018-04-17       Impact factor: 5.157

7.  Small Heterodimer Partner and Fibroblast Growth Factor 19 Inhibit Expression of NPC1L1 in Mouse Intestine and Cholesterol Absorption.

Authors:  Young-Chae Kim; Sangwon Byun; Sunmi Seok; Grace Guo; H Eric Xu; Byron Kemper; Jongsook Kim Kemper
Journal:  Gastroenterology       Date:  2018-12-03       Impact factor: 22.682

8.  A dysregulated acetyl/SUMO switch of FXR promotes hepatic inflammation in obesity.

Authors:  Dong-Hyun Kim; Zhen Xiao; Sanghoon Kwon; Xiaoxiao Sun; Daniel Ryerson; David Tkac; Ping Ma; Shwu-Yuan Wu; Cheng-Ming Chiang; Edward Zhou; H Eric Xu; Jorma J Palvimo; Lin-Feng Chen; Byron Kemper; Jongsook Kim Kemper
Journal:  EMBO J       Date:  2014-11-25       Impact factor: 11.598

Review 9.  Bile acids are nutrient signaling hormones.

Authors:  Huiping Zhou; Phillip B Hylemon
Journal:  Steroids       Date:  2014-05-10       Impact factor: 2.668

10.  MicroRNA-210 Promotes Bile Acid-Induced Cholestatic Liver Injury by Targeting Mixed-Lineage Leukemia-4 Methyltransferase in Mice.

Authors:  Young-Chae Kim; Hyunkyung Jung; Sunmi Seok; Yang Zhang; Jian Ma; Tiangang Li; Byron Kemper; Jongsook Kim Kemper
Journal:  Hepatology       Date:  2020-02-14       Impact factor: 17.425

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.